Fitzgerald Advisors · Direct portfolio brokerage

Medical Bad Debt Divestiture

Medical bad-debt divestiture requires a patient-account, eligibility, privacy, financial-assistance, and buyer-conduct review before any controlled portfolio process is considered.

At a glance: Evaluate patient-account eligibility, documentation, privacy, and buyer conduct before considering a sale. Medical bad-debt divestiture requires a

Transaction hub: Sell a Portfolio: medical bad debt divestiture

At a glance: Medical bad-debt divestiture requires a patient-account, eligibility, privacy, financial-assistance, and buyer-conduct review before any controlled portfolio process is considered.

Key Takeaways

  • Define the asset, objective, scope, and decision timeline before outreach.
  • Keep data, documentation, ownership, servicing, and material exceptions connected.
  • Compare complete economics and execution terms rather than a headline number alone.
  • Document responsibilities, transfer controls, and the next review step.

Establish what is actually owed

Separate patient responsibility from pending insurance, disputed charges, contractual adjustments, charity care, and financial-assistance decisions. Record the service and billing dates, balance composition, prior notices, collection history, and any pending appeal or adjustment.

Exclude or separately resolve accounts that cannot support the proposed transfer or recovery strategy. A large gross receivable balance does not establish a saleable balance.

Review hospital and privacy obligations

For tax-exempt hospital facilities subject to Section 501(r), extraordinary collection actions require reasonable efforts to determine financial-assistance eligibility. A debt sale can be an extraordinary collection action; regulatory exceptions depend on specific conditions. Review the IRS billing and collection requirements with qualified counsel before setting eligibility and contract terms.

HIPAA permits certain uses and disclosures for payment, subject to its requirements and limitations. That does not establish unrestricted permission to disclose a patient data set to a prospective purchaser. Determine the permitted purpose, recipient role, necessary agreements, and minimum information required using the HHS guidance and transaction-specific advice.

Define the buyer’s operating restrictions

Review areaEvidence and decision
Patient responsibilityReconciliation of insurer activity, payments, adjustments, and assistance
EligibilityDocumented exclusions, pending disputes, appeals, and required reviews
Privacy and securityAccess rules, permitted fields, transfer controls, retention, and incident response
Collection conductAgreed patient protections, complaints, disputes, reporting, and prohibited actions
Post-sale changesProcess for payments, recalls, corrections, assistance determinations, and refunds

Scroll horizontally to read the full table.

Verify any claimed license, certification, or control assessment directly. A certification label alone does not establish legal compliance or fitness for this portfolio.

Treat credit reporting as a separate review

Do not assume that every medical account may be reported, or that one blanket federal prohibition answers the question. The CFPB’s medical-debt credit-reporting rule was vacated in July 2025, as reflected in its FCRA resources. Applicable law, bureau policies, agreements, and account facts still require review.

Evaluate a controlled transaction

Start with an aggregate portfolio summary and document inventory. Compare a sale with retained collection, resolution, or other permitted treatment. A proposed buyer, price, and transfer structure remain subject to diligence and agreed terms.

Sources and Further Reading

This page provides general information for institutional and commercial readers. It is not legal, tax, accounting, investment, or transaction-specific advice. Requirements and outcomes depend on the assets, parties, jurisdictions, and agreements. Obtain appropriate professional advice for a proposed transaction.

Back to top

Direct answers

Frequently asked questions

What should a reader review first when evaluating medical bad debt divestiture | fitzgerald advisors?

Start by defining the asset class, transaction objective, information available, and decision timeline. A controlled review can then identify the right diligence path and the most relevant sell debt portfolios resources.

How does medical bad debt divestiture | fitzgerald advisors fit into the Fitzgerald Advisors research framework?

Medical Bad Debt Divestiture | Fitzgerald Advisors is organized under the Sell a Portfolio hub. That hub connects the topic to related guidance on documentation, valuation, buyer or seller fit, and controlled transaction execution.

Discuss a portfolio mandate · Sell debt portfolios · Buy debt portfolios

A direct broker desk for qualified buyers and sellers of debt, loan, judgment, CRE, note, and specialty-finance portfolios.